HCAT Health Catalyst

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:

  • The Cantor Global Healthcare Conference, being held in New York, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, September 3, 2025 at 9:10am ET.
  • The Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, September 4, 2025 at 1:30pm ET. The webcast link will be available online at .
  • The Morgan Stanley 23rd Annual Global Healthcare Conference, being held in New York, including a fireside chat with Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Tuesday, September 9, 2025 at 11:30am ET.

About Health Catalyst

Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.

Health Catalyst Investor Relations Contact:

Matt Hopper

SVP of Finance and Head of Investor Relations

+1 (855) 309-6800

Health Catalyst Media Contact:

Kathryn Mykleseth

Director of PR and Communications



EN
21/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Health Catalyst

 PRESS RELEASE

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Participate in Upcoming Investor Conferences SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences: The Cantor Global Healthcare Conference, being held in New York, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of ...

 PRESS RELEASE

Health Catalyst Reports Second Quarter 2025 Results

Health Catalyst Reports Second Quarter 2025 Results SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. “For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric.” said Dan Burton, CEO of Health Catalyst. “I als...

 PRESS RELEASE

Health Catalyst to Announce Second Quarter 2025 Operating Results and ...

Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025 SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed ...

 PRESS RELEASE

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Participate in Upcoming Investor Conferences SALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector 1x1 Conference, being held in Boston, on Tuesday, June 3, 2025.The Goldman Sachs 46th Annual Global Healthcare Conference, bein...

 PRESS RELEASE

Health Catalyst Reports First Quarter 2025 Results

Health Catalyst Reports First Quarter 2025 Results SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. “For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric,” said Dan Burton, CEO of Health Catalyst. “Addit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch